Costmary (Tanacetum balsamita)

Costmary (Tanacetum balsamita) is a aromatic herb containing luteolin, apigenin, and camphor-derived terpenoids that drive its antioxidant and cholinesterase-inhibiting activity. Its polyphenolic compounds neutralize free radicals and suppress acetylcholinesterase and butyrylcholinesterase enzymes, which are central targets in cognitive health research.

Origin & History

Costmary (Tanacetum balsamita) is a perennial aromatic herb native to southern Europe and western Asia. It is cultivated for its leaves, flowers, and roots, which are processed via solvent extraction or essential oil distillation, revealing high phenolic and flavonoid content.

Historical & Cultural Context

Traditionally, costmary has been used in Mediterranean, Balkan, and South American folk medicine for its carminative, cardiotonic, and hepatoprotective properties. In European history, it was used as a diuretic, laxative, and for childbirth pain relief.

Health Benefits

• Strong antioxidant activity, particularly from flower heads, shown in in vitro studies (DPPH 84.54 mgTE/g, ABTS 96.35 mgTE/g).
• Inhibition of acetylcholinesterase and butyrylcholinesterase by leaves, suggesting potential for cognitive health support (in vitro, 2.11 mg GALAE/g and 2.43 mg GALAE/g, respectively).
• Roots demonstrate enzyme inhibition, affecting α-glucosidase, α-amylase, and lipase, indicating potential for metabolic health (in vitro).
• Cytotoxic effects on leukemic cells, reducing cell viability in a dose-dependent manner (>2 µg/mL), though further research needed.
• Traditionally used for inflammatory diseases and as a sedative, suggesting potential for supporting general health and wellness.

How It Works

Costmary's flavonoids, particularly luteolin and apigenin found in its leaves and flower heads, donate hydrogen atoms to neutralize DPPH and ABTS free radicals, measured at 84.54 mgTE/g and 96.35 mgTE/g respectively in vitro. The leaf extract inhibits acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) at potencies of 2.11 mg GALAE/g and 2.43 mg GALAE/g, preventing the breakdown of acetylcholine at cholinergic synapses. This dual enzyme inhibition mirrors the pharmacological mechanism of approved cholinesterase-inhibitor drugs used in cognitive decline, suggesting relevance to the cholinergic signaling pathway.

Scientific Research

No human clinical trials or meta-analyses have been conducted on Tanacetum balsamita. The evidence available is limited to in vitro studies, such as one found in PMC9824382, which highlights its antioxidant and enzyme inhibitory activities.

Clinical Summary

Current evidence for costmary is limited to in vitro studies measuring antioxidant capacity via DPPH and ABTS assays and enzymatic inhibition assays for AChE and BChE; no human clinical trials have been published. The antioxidant data (DPPH: 84.54 mgTE/g; ABTS: 96.35 mgTE/g) and cholinesterase inhibition values (2.11–2.43 mg GALAE/g) were derived from standardized laboratory assays on plant extracts, not from dosing in living organisms. While these in vitro findings are promising, they cannot be directly extrapolated to human therapeutic outcomes without controlled clinical trials. The evidence base should be characterized as preliminary, and claims about cognitive or antioxidant benefits in humans remain speculative at this stage.

Nutritional Profile

Costmary (Tanacetum balsamita) is a aromatic herb with limited comprehensive nutritional analysis in literature, but the following is documented or reasonably characterized: Bioactive compounds dominate its profile. Volatile essential oils constitute a primary fraction, with camphor (up to 40-60% of essential oil fraction in some chemotypes), 1,8-cineole (eucalyptol, ~10-20%), davadone, and chrysanthenyl acetate as key terpene constituents. Polyphenolic compounds are well-represented: flavonoids including luteolin, apigenin, and quercetin glycosides have been identified in leaf and flower fractions; phenolic acids including chlorogenic acid, caffeic acid, and rosmarinic acid contribute significantly to the high antioxidant values recorded (DPPH 84.54 mgTE/g and ABTS 96.35 mgTE/g in flower heads). Sesquiterpene lactones, characteristic of the Asteraceae family, are present and likely contribute to enzyme inhibitory activity. As a leafy herb, proximate composition per 100g fresh weight is estimated to include: moisture ~80-85g, crude fiber ~2-3g, protein ~2-3g, with trace fats. Mineral content likely includes calcium, potassium, and magnesium typical of aromatic Mediterranean herbs, though precise quantification for this species is not extensively published. Vitamins A (as beta-carotene from chlorophyll-rich leaves) and C are presumed present based on botanical family characteristics. Bioavailability note: lipophilic terpenes and camphor are readily absorbed via mucous membranes and GI tract; polyphenol bioavailability is moderate and matrix-dependent, likely enhanced by the herb's use in infusions or teas which extract water-soluble phenolics efficiently.

Preparation & Dosage

No clinically studied dosages in humans are available. In vitro studies suggest extract concentrations of >2 µg/mL for various activities. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Ginkgo biloba, Rosemary, Sage, Lemon Balm, Gotu Kola

Safety & Interactions

Costmary contains thujone and camphor-related monoterpenes, which can be neurotoxic in high doses, and internal consumption of concentrated extracts should be approached with caution. Because of its cholinesterase-inhibiting properties, it may theoretically potentiate the effects of pharmaceutical cholinesterase inhibitors such as donepezil or rivastigmine, increasing risk of cholinergic side effects like nausea, bradycardia, and excessive salivation. Costmary belongs to the Asteraceae family, meaning individuals with known allergies to ragweed, chrysanthemums, or related plants may experience cross-reactive allergic responses including contact dermatitis. Pregnant or breastfeeding women should avoid medicinal use of costmary, as its thujone content poses potential uterotonic and embryotoxic risks, consistent with traditional warnings against Tanacetum species during pregnancy.